Last edition
News about Drug Discovery & Development
India’s small and mid-sized pharmaceutical manufacturers are raising alarms over new good manufacturing practice (GMP) and bio-equivalence mandates, warning that the regulations could widen the gap between large companies and micro, small, and medium enterprises (MSMEs).
Drug Discovery & Development | 13/10/2025 | By Darshana | 770
Zenas BioPharma Signs USD 2 Billion Licensing Deal with InnoCare for Autoimmune Drugs
Zenas BioPharma has entered into a licensing agreement with China’s InnoCare Pharma worth up to USD 2 billion to develop and commercialise three autoimmune drug candidates, including a late-stage treatment for multiple sclerosis.
Drug Discovery & Development | 09/10/2025 | By Darshana | 401
Through the partnership among Sai Life Sciences, Agility Life Sciences and Centrix Pharma Solutions, customers will have access to integrated drug substance and drug product development, helping them move efficiently from pre-clinical studies to First-In-Human (FIH) clinical trials and beyond.
Drug Discovery & Development | 09/10/2025 | By Dineshwori | 295
BD and Opentrons Collaborate to Automate Single-Cell Multiomics Workflows
BD (Becton, Dickinson and Company) and Opentrons Labworks, Inc. have entered into a multi-year collaboration to accelerate advances in single-cell multiomics research by integrating robotic automation into critical laboratory workflows.
Drug Discovery & Development | 08/10/2025 | By Darshana | 403
Omalizumab, the active ingredient in Xolair, is a prescription biologic used to improve the control of severe persistent allergic asthma in patients aged six years and older when blood tests confirm immunoglobulin E (IgE) involvement.
Drug Discovery & Development | 07/10/2025 | By Darshana | 330
Illumina Launches BioInsight to Drive Multiomic Data and AI-Powered Drug Discovery
Illumina, Inc., a global leader in genomics and precision health, has announced the launch of BioInsight, a new business designed to meet the growing demand for deeper biological insights driven by large-scale multiomic data.
Drug Discovery & Development | 04/10/2025 | By Darshana | 902
Bristol Myers and Takeda Join AI Consortium to Accelerate Drug Discovery
Bristol Myers Squibb and Takeda Pharmaceuticals have agreed to collaborate in a new AI-driven drug discovery initiative, pooling proprietary molecular structure datasets to train an advanced AI model known as OpenFold3.
Drug Discovery & Development | 01/10/2025 | By Darshana | 816
Concept Life Sciences Unveils Major Expansion of UK Drug Discovery Facilities
Concept Life Sciences, a multi-disciplined contract research organisation, has officially opened its newly expanded integrated drug discovery facilities at its Chapel-en-le-Frith headquarters, establishing one of the UK’s largest drug discovery research sites.
Drug Discovery & Development | 30/09/2025 | By Darshana | 264
Akums Highlights Lacosamide's Versatility in Epilepsy Management
Akums Drugs & Pharmaceuticals reaffirmed lacosamide, a well-established antiepileptic drug (AED), as a versatile and effective option for patients with epilepsy across age groups and clinical settings.
Drug Discovery & Development | 22/09/2025 | By Dineshwori | 239
Orforglipron by Lily Shows Significant Weight Loss and Cardiometabolic Gains in ATTAIN-1 Results
Orforglipron by Eli Lily demonstrated significant improvements across key cardiometabolic risk factors, supporting its potential as a treatment option for millions living with obesity.
Drug Discovery & Development | 18/09/2025 | By Dineshwori | 560
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy